No profile photo available

Ka-Ho Wong, PhD, MBA

Languages spoken: English

Academic Information

Departments Primary - Neurology

Academic Office Information

Ka-Ho.Wong@hsc.utah.edu

Education History

Externship Intermountain Health Care, Utah Heart Clinic
 Externship
Undergraduate University of Utah
 BS
Graduate Training University of the People
 MBA
Doctoral Training University of Utah Spencer Fox Eccles School of Medicine
 PhD
Fellowship University of Utah
 Fellow

Selected Publications

Journal Article

  1. Hoshina Y, Seay M, Vegunta S, Stulberg EL, Wright MA, Wong KH, Smith TL, Shimura D, Clardy SL (2025). Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. J Neuroophthalmol, 45(1), 36-43.
  2. Wong KH, Day GS, Torner JC, Cudkowicz M, Coffey CS, Cho HJS, Utz U, Clifford DB, Katz E, Ratchford J, Flavin S, Dialino-Felix A, Dill LM, Kamp C, Klawiter EC, Singleton JR, Fedler J, Klingner EA, Ecklund D, Klements D, Costigan M, Steinhart E, Pearson B, Desir C, Dalmau JO, Titulaer MJ, Clardy SL (2025). A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. Neurol Open Access, 1(2).
  3. Fayed M, Peng TJ, Skolarus LE, Sheth KN, Wong KH, de Havenon A (2025). Racial and Ethnic Disparities in Ischemic Stroke Severity in the National Inpatient Sample Between 2018 and 2021. Stroke, 56(5), 1290-1294.
  4. Hoshina Y, Liu S, Wright MA, Delic A, Wong KH, Kadish R, Galli J, Rose JW, Greenlee JE, Sold�n MMP, Klein J, Peterson LK, Smith TL, Clardy SL (2025). Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. J Neuroimmunol, 407, 578709.
  5. Wong KH, Anderson CD, Peterson C, Bouldin E, Littig L, Krothapalli N, Francis T, Kim Y, Cucufate G, Rosand J, Sheth KN, de Havenon A (2025). Rising Cognitive Disability as a Public Health Concern Among US Adults: Trends From the Behavioral Risk Factor Surveillance System, 2013-2023. Neurology, 105(8), e214226.
  6. Wong KH, Zeng E, Smith TL, King JB, Marini E, Sorenson A, Hwang H, Stein C, Francis T, Rose JW, Reddy VK, de Havenon AH, Clardy SL (2025). Medicare Part D Use and Costs for Immune-Mediated Neurologic Therapies. JAMA Netw Open, 8(10), e2538277.
  7. Noroozi Gilandehi S, Wong KH, Francis T, Wright MA, Lord J, Stehlik J, Kemeyou L, Smith T, Clardy SL (2024). Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation. Neurol Neuroimmunol Neuroinflamm, 11(2), e200196.
  8. Hoshina Y, Delic A, Wong KH, Lyden S, Kadish R, Smith TL, Wright MA, Shimura D, Clardy SL (2024). Vasculitis in the Central Nervous System: Etiology, Characteristics, and Outcomes in a Large Single-Center Cohort. Neurohospitalist, 14(2), 129-139.
  9. Heath T, Shrishail N, Wong KH, Johnston KC, Sharma R, Ney JP, Sheth KN, de Havenon AH (2024). Trends in American Indian/Alaskan native self-reported stroke prevalence and associated modifiable risk factors in the United States from 2011-2021. J Stroke Cerebrovasc Dis, 33(6), 107650.
  10. Stulberg EL, Lisabeth L, Schneider ALC, Skolarus L, Kershaw KN, Zheutlin AR, Harris BRE, Sarpong D, Wong KH, Sheth KN, de Havenon A (2024). Correlations of Socioeconomic and Clinical Determinants with United States County-Level Stroke Prevalence. Ann Neurol, 96(4), 739-744.
  11. de Havenon A, Stulberg EL, Littig L, Wong KH, Sarpong D, Li V, Sharma R, Falcone GJ, Williamson JD, Pajewski NM, Gottesman RF, Brickman AM, Sheth KN (2024). Socioeconomic and medical determinants of state-level subjective cognitive decline in the United States. Alzheimers Dement, 20(11), 7567-7579.
  12. De Almeida BI, Smith TL, Delic A, Esquibel L, Galli J, Millsap L, Paz Sold�n MM, Cortez MM, Rose J, Greenlee JE, Gundlapalli AV, Hill HR, Wong KH, Clardy SL (2023). Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of Life. Neurol Neuroimmunol Neuroinflamm, 10(3).
  13. Wong KH, Muddasani V, Peterson C, Sheibani N, Arkin C, Cheong I, Majersik JJ, Biffi A, Petersen N, Falcone GJ, Sansing LH, de Havenon AH (2023). Baseline Serum Biomarkers of Inflammation and Subsequent Visit-to-Visit Blood Pressure Variability: A Post Hoc Analysis of MESA. Am J Hypertens, 36(3), 144-147.
  14. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy S (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Frontiers in neurology, 14, 1174116.
  15. Majersik JJ, Wong KH, O'Donnell SM, Johnson J, Garcia-Esperon C, Hamilton BJ, Tekiela P, Ledyard HK, Taillac P (2023). Telestroke value through the eyes of emergency medicine providers: A counterfactual analysis. Heliyon, 9(4), e14767.
  16. Goldstein ED, Garg G, Navarro K, Wolcott Z, Yaghi S, Wong KH, McLean K, de Havenon AH (2023). Statin Usage Increases White Matter Hyperintensities: A Post Hoc Analysis of SPRINT-MIND. Neurologist, 28(2), 94-98.
  17. SVIN COVID-19 Global SAH Registry (2022). Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up.(Epub ahead of print). J Neurol Neurosurg Psychiatry.
  18. Petersen NH, Kodali S, Meng C, Li F, Nguyen CK, Peshwe KU, Strander S, Silverman A, Kimmel A, Wang A, Anadani M, Almallouhi E, Spiotta AM, Kim JT, Giles JA, Keyrouz SG, Farooqui M, Zevallos C, Maier IL, Psychogios MN, Liman J, Riou-Comte N, Richard S, Gory B, Quintero Wolfe S, Brown PA, Fargen KM, Mistry EA, Fakhri H, Mistry AM, Wong KH, de Havenon A, Nascimento FA, Kan P, Matouk C, Ortega-Guti�rrez S, Sheth KN (2022). Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study. Stroke, 53(4), 1216-1225.
  19. Goldstein ED, Wolcott Z, Garg G, Navarro K, Delic A, Yaghi S, Sederholm B, Prabhakaran S, Wong KH, McLean K, de Havenon AH (2022). Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND. Stroke, 53(8), 2435-2440.
  20. Prasad A, Kobsa J, Kodali S, Bartolome D, Begunova L, Quispe-Orozco D, Farooqui M, Zevallos C, Ortega-Guti�rrez S, Anadani M, Almallouhi E, Spiotta AM, Giles JA, Keyrouz SG, Kim JT, Maier IL, Liman J, Psychogios MN, Riou-Comte N, Richard S, Gory B, Quintero Wolfe S, Brown PA, Fargen KM, Mistry EA, Fakhri H, Mistry A, Wong KH, Nascimento FA, Kan P, de Havenon A, Sheth KN, Petersen NH (2022). Temporal profiles of systolic blood pressure variability and neurologic outcomes after endovascular thrombectomy. Eur Stroke J, 7(4), 365-375.
  21. Pope B, Wolcott Z, Castillo M, Jin J, Wong KH, Havenon A, Yaghi S, Goldstein ED (2022). Mutation of breast cancer susceptibility genes increases cerebral microbleeds: A pilot study. J Stroke Cerebrovasc Dis, 31(11), 106729.
  22. Taussky P, Agnoletto G, Grandhi R, Alexander MD, Wong KH, Albers GW, de Havenon A (2021). Prediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 ". J Neurointerv Surg, 13(9), 805-808.
  23. Navarro KS, Wong KH, Ibrahim MM, de Havenon AH, Goldstein ED (2021). The association between transthoracic echocardiogram parameters and white matter hyperintensities. Clin Neurol Neurosurg, 206, 106672.
  24. Sheibani N, Wong KH, Turan TN, Yeatts SD, Gottesman RF, Prabhakaran S, Rost NS, de Havenon A (2021). White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial. J Stroke Cerebrovasc Dis, 30(6), 105764.
  25. de Havenon A, Delic A, Yaghi S, Wong KH, Majersik JJ, Stulberg E, Tirschwell D, Anadani M (2021). Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up. Am J Hypertens, 34(12), 1269-1275.
  26. Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy SL (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurol Neuroimmunol Neuroinflamm, 8(6).
  27. de Havenon A, Anadani M, Prabhakaran S, Wong KH, Yaghi S, Rost N (2021). Increased Blood Pressure Variability and the Risk of Probable Dementia or Mild Cognitive Impairment: A Post Hoc Analysis of the SPRINT MIND Trial. J Am Heart Assoc, 10(18), e022206.
  28. Baradaran H, Delic A, Wong KH, Sheibani N, Alexander M, McNally JS, Majersik JJ, De Havenon A (2021). Using Ultrasound and Inflammation to Improve Prediction of Ischemic Stroke: A Secondary Analysis of the Multi-Ethnic Study of Atherosclerosis. Cerebrovasc Dis Extra, 11(1), 37-43.
  29. Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (2020). Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke, 51(12), 3733-3736.
  30. de Havenon A, Stoddard G, Saini M, Wong KH, Tirschwell D, Bath P, VISTA-Acute Collaborators (2019). Increased blood pressure variability after acute ischemic stroke increases the risk of death: A secondary analysis of the Virtual International Stroke Trial Archive. JRSM Cardiovasc Dis, 8, 2048004019856496.
  31. de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (2019). Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study. AJNR Am J Neuroradiol, 40(8), 1369-1373.
  32. de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (2019). Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Stroke, 50(11), 3170-3176.
  33. de Havenon A, Majersik JJ, Stoddard G, Wong KH, McNally JS, Smith AG, Rost NS, Tirschwell DL (2018). Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage. Stroke, 49(8), 1981-1984.

Review

  1. Hoshina Y, Smith TL, Mstat AD, Wong KH, Peterson LK, Zekeridou A, Aboseif A, Coffey C, Wright MA, Banwell B, Dialino-Felix A, Flavin S, Dill L, Titulaer MJ, Day GS, Clardy SL (2025). An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote. [Review]. J Neuroimmunol, 405, 578651.

Case Report

  1. Hoshina Y, Galli J, Wong KH, Kovacsovics T, Steinbach M, Salzman KL, McNally JS, Lancaster E, Paz Sold�n MM, Clardy SL (2022). GABA-A Receptor Encephalitis After Autologous Hematopoietic Stem Cell Transplant forMultiple Myeloma: Three Cases and Literature Review. Neurol Neuroimmunol Neuroinflamm, 9(6).

Letter

  1. Peterson C, Wong KH, Stulberg EL, Taylor K, Cramer SC, de Havenon AH (2021). Effect of Premorbid Anxiolytic Medications on Ischemic Stroke Functional Outcome. [Letter to the editor]. Stroke, 52(2), e51-e52.